Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion

American Journal of Health-System Pharmacy

Volumn 67, Issue 11, 2010, Pages 914-918

  Crill, Catherine M ^a,b   Hak, Emily B ^c,d   Robinson, Lawrence A ^e   Helms, Richard A ^d,f,g  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

^c UTHSC   (United States)

^d CFRC   (United States)

^e Supportive Oncology Services   (United States)

^f Department of Clinical Pharmacy ^*  (United States)

^g UTHSC   (United States)

Author keywords

Compounding; Contamination; Fat emulsions; Injections; Packaging; Pediatrics; Stability; Sterile products; Storage

Indexed keywords

LIPID EMULSION;

ARTICLE; BACTERIAL GROWTH; BACTERIUM CONTAMINATION; BLOOD CULTURE; CITROBACTER FREUNDII; CLINICAL EVALUATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTAINER; CULTURE TECHNIQUE; DISEASE ASSOCIATION; HUMAN; INCUBATOR; KLEBSIELLA OXYTOCA; MALASSEZIA FURFUR; MICROBIAL CONTAMINATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SYRINGE; BACTERIUM; COMPARATIVE STUDY; DRUG CONTAMINATION; DRUG FORMULATION; DRUG PACKAGING; DRUG STORAGE; HOSPITAL PHARMACY; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; STANDARD; TIME;

BACTERIA; DRUG COMPOUNDING; DRUG CONTAMINATION; DRUG PACKAGING; DRUG STORAGE; FAT EMULSIONS, INTRAVENOUS; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; PHARMACY SERVICE, HOSPITAL; SYRINGES; TIME FACTORS;

EID: 77955862485     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp090199     Document Type: Article

References (32)

1. Kleinman RE, ed. Pediatric nutrition handbook. 6th ed. Elk Grove, IL: American Academy of Pediatrics; 2009:529.
2. Brennan MF, O'Connel RC, Rosol JA et al. Growth of Candida albicans in nutritive solutions given parenterally. Arch Surg. 1971; 103:705-8.
3. Deitel M, Kaminsky VM, Fuksa M. Growth of common bacteria and Candida albicans in 10% soybean oil emulsion. Can J Surg. 1975; 18:531-5.
4. Melly MA, Meng HC, Schaffner W. Microbial growth in lipid emulsions used in parenteral nutrition. Arch Surg. 1975; 110:1479-81.
5. Keammerer D, Mayhall CG, Hall GO et al. Microbial growth patterns in intravenous fat emulsions. Am J Hosp Pharm. 1983; 40:1650-3. (Pubitemid 13009345)
6. Kim CH, Lewis DE, Kumar A. Bacterial and fungal growth in intravenous fat emulsions. Am J Hosp Pharm. 1983; 40:2159-61. (Pubitemid 14200872)
7. Crocker KS, Noga R, Filibeck DJ et al. Microbial growth comparisons of five commercial parenteral lipid emulsions. J Parenter Enteral Nutr. 1984; 8:391-5. (Pubitemid 14045900)
8. Jarvis WR, Highsmith AK. Bacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol. 1984; 19:17-20. (Pubitemid 14213295)
9. Ebbert ML, Farraj M, Hwang LT. The incidence and clinical significance of intravenous fat emulsion contamination during infusion. J Parenter Enteral Nutr. 1987; 11:42-5. (Pubitemid 17009515)
10. Reiter PD. Sterility of intravenous fat emulsion in plastic syringes. Am J Health-Syst Pharm. 2002; 598:1857-9.
11. Reiter PD, Robles J, Dowell EG. Effect of 24-hour intravenous tubing set change on the sterility of repackaged intravenous fat emulsion in neonates. Ann Pharmacother. 2004; 38:1603-7. (Pubitemid 39297754)
12. McKee KT Jr, Melly MA, Greene HL et al. Gram-negative bacillary sepsis associated with use of lipid emulsion in parenteral nutrition. Am J Dis Child. 1979; 133:649-50. (Pubitemid 9212672)
13. Jarvis WR, Highsmith AK, Allen JR et al. Polymicrobial bacteremia associated with lipid emulsion in a neonatal intensive care unit. Pediatr Infect Dis. 1983; 2:203-8. (Pubitemid 13040523)
14. De Beaufort AJ, Bernards AT, Dijkshoorn L et al. Acinetobacter junii causes life-threatening sepsis in preterm infants. Acta Paediatr. 1999; 88:772-5. (Pubitemid 29350149)
15. American Society for Parenteral and Enteral Nutrition (ASPEN) Board of Directors. Definition of terms, style, and conventions used in ASPEN board of directors-approved documents. www.nutritioncare.org/wcontent.aspx?id=4714 (accessed 2010 Apr 16).
16. Sacks G, Driscoll DF. Does lipid hang time make a difference? Time is of the essence. Nutr Clin Pract. 2002; 17:284-90.
17. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR. 2002; 51:1-29.
18. Mirtallo J, Canada T, Johnson D et al. Safe practices for parenteral nutrition. J Parenter Enteral Nutr. 2004; 28(suppl):S39-70. [Erratum, J Parenter Enteral Nutr. 2006; 30:177.]
19. Pharmaceutical compounding - sterile preparations (general information chapter 797). In: The United States pharmacopeia, 30th rev., and The national formulary, 25th ed. Rockville, MD: United States Pharmacopeial Convention; 2007.
20. Danker WM, Spector SA, Fierer J et al. Malassezia fungemia in neonates and adults: complication of hyperalimentation. Rev Infect Dis. 1987; 9:742-53.
21. Fairchild KD, Paterson A, Gumpper KF. Overdose of intravenous fat emulsion in a preterm infant: case report. Nutr Clin Pract. 1999; 14:116-9.
22. Chuo J, Lambert G, Hicks RW. Intralipid medication errors in the neonatal intensive care unit. Jt Comm J Qual Patient Saf. 2007; 33:104-11.
23. Low E, Ryan CA. Overdose of intravenous intralipid in a premature neonate. Jt Comm J Qual Patient Saf. 2007; 33:588-9.
24. Hicks RW, Becker SC, Chuo J. A summary of NICU fat emulsion medication errors and nursing services. Data from MEDMARX. Adv Neonatal Care. 2007; 7:299-310.
25. D'Angio R, Quercia R, Treiber NK et al. The growth of microorganisms in total parenteral nutrition admixtures. J Parenter Enteral Nutr. 1987; 11:394-7. (Pubitemid 17099991)
26. Vasilakis A, Apelgren KN. Answering the fat emulsion contamination question: three in one admixture vs conventional total parenteral nutrition in a clinical setting. J Parenter Enteral Nutr. 1988; 12:356-9.
27. Scheckelhoff DJ, Mirtallo JM, Ayers LW et al. Growth of bacteria and fungi in total nutrient admixtures. Am J Hosp Pharm. 1986; 43:73-7. (Pubitemid 16177436)
28. Gilbert M, Gallagher SC, Eads M et al. Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion. J Parenter Enteral Nutr. 1986; 10:494-7. (Pubitemid 16020966)
29. Didier ME, Fischer S, Maki DG. Total nutrient admixtures appear safer than lipid emulsion alone as regards microbial contamination: growth properties of microbial pathogens at room temperature. J Parenter Enteral Nutr. 1998; 22:291-6. (Pubitemid 28406841)
30. Rowe CE, Fukuyama TT, Martinoff JT. Growth of microorganisms in total nutrient admixtures. Drug Intell Clin Pharm. 1987; 21:633-8. (Pubitemid 17098376)
31. Mershon J, Nogami W, Williams JM et al. Bacterial/fungal growth in a combined parenteral nutrition solution. J Parenter Enteral Nutr. 1986; 10:498-502. (Pubitemid 16029365)
32. Trissel LA. Sterility of fat emulsion in plastic syringes. Am J Health-Syst Pharm. 2003; 60:196-7. Letter.